Refoxy Pharmaceuticals is a biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.

GEMESYS develops AI chips using memristor technology for efficient on-device training and inference.